Evidence 1
Activity
Activity
50% Hemolysis
Toxicity
1420 µM
Hemolytic
Cytotoxic
50% Hemolysis | 1420 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Macrocyclic Antimicrobial Peptides Engineered from ?-Conotoxin. | Curr Pharm Des | 2017